#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3840	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2510	341.8	0	.	n	.	0	C451T	SNP	451	451	C	798	798	T	443	T,G	398,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3840	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2510	341.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1531	1531	C	454	C,A,G	395,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6480	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4168	351.9	0	.	n	.	0	T695C	SNP	695	695	T	1267	1267	C	448	C,A	363,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6480	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4168	351.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2543	2543	C	443	C,A	384,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6480	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4168	351.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2617	2617	A	424	A,G	360,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6480	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4168	351.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3169	3169	C	437	C,T	376,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	462	folP	855	855	100.0	folP.l6.c4.ctg.1	1929	56.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1246	1248	AGC	64;64;63	A;G;C	60;60;59	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	783	1032	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3986	60.2	1	SNP	p	S91F	1	.	.	271	273	TTC	877	879	TTC	68;68;68	T;T;C	59;58;62	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	783	1032	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3986	60.2	1	SNP	p	G95N	0	.	.	283	285	GGC	889	891	GGC	71;71;71	G;G,T;C	65;63,1;61	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	783	1032	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3986	60.2	1	SNP	p	D95G	1	.	.	283	285	GGC	889	891	GGC	71;71;71	G;G,T;C	65;63,1;61	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	783	1032	gyrA	2751	688	98.85	gyrA.l15.c4.ctg.2	669	0.9	0	.	p	.	0	S625R	NONSYN	1873	1875	AGC	154	156	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	783	1032	gyrA	2751	688	98.85	gyrA.l15.c4.ctg.2	669	0.9	0	.	p	.	0	R628C	NONSYN	1882	1884	CGT	163	165	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	783	1032	gyrA	2751	688	98.85	gyrA.l15.c4.ctg.2	669	0.9	0	.	p	.	0	E689fs	FSHIFT	2065	2065	G	346	346	G	ND	ND	ND	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	440	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1654	63.6	1	SNP	p	G45D	0	.	.	133	135	GGC	602	604	GGC	85;86;86	G;G;C	77;75;78	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	272	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1455	43.0	0	.	n	.	0	A197.	DEL	197	197	A	783	783	A	108	A	95	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3553	66.8	1	SNP	p	D86N	0	.	.	256	258	GAC	892	894	GAC	73;73;74	G;A,C,G;C,A	48;39,2,1;53,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3553	66.8	1	SNP	p	R87I	0	.	.	259	261	CGT	895	897	CGT	74;74;75	C;G;T,C	63;48;53,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3553	66.8	1	SNP	p	S87R	1	.	.	259	261	CGT	895	897	CGT	74;74;75	C;G;T,C	63;48;53,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3553	66.8	1	SNP	p	R87W	0	.	.	259	261	CGT	895	897	CGT	74;74;75	C;G;T,C	63;48;53,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1004	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3553	66.8	1	SNP	p	S88P	0	.	.	262	264	TCC	898	900	TCC	74;73;73	T,C;C,T;C	55,1;59,2;64	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1126	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3376	78.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1927	1929	GGC	104;106;107	G;G;C,A	89;91;82,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1697	1699	GCC	115;118;120	G;C;C,A	104;107;108,1	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1700	1702	ATG	120;120;120	A,C;T,C;G	108,1;108,1;108	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1712	1714	ACC	123;125;125	A,C,G;C;C	107,1,1;112;112	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1712	1714	ACC	123;125;125	A,C,G;C;C	107,1,1;112;112	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2213	2215	ACC	97;97;94	A,C;C,A,G;C	82,1;83,1,1;84	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2267	2269	GCG	94;94;94	G,T;C;G,T	83,1;67;77,2	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2267	2269	GCG	94;94;94	G,T;C;G,T	83,1;67;77,2	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2390	2392	GGT	62;63;64	G;G,T;T,C	54;52,3;54,2	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2399	2401	AGC	53;53;55	A,G;G,C;C,G	34,3;40,1;39,2	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	964	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2715	78.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2417	2419	CCG	46;44;43	C,T,G;C,G;G	36,2,1;36,1;37	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1316	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3760	78.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1915	1917	CCG	110;110;109	C,G,T;C;G,C	85,2,1;99;74,7	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	556	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2374	54.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	855	855	C	50	C	36	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	686	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2260	71.7	1	SNP	p	G120K	1	.	.	358	360	AAG	934	936	AAG	87;88;86	A,C;A;G	82,1;84;82	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	686	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2260	71.7	1	SNP	p	N121D	0	.	.	361	363	AAC	937	939	AAC	86;86;86	A;A,C;C,A	82;81,1;79,3	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	686	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2260	71.7	1	SNP	p	A121N	1	.	.	361	363	AAC	937	939	AAC	86;86;86	A;A,C;C,A	82;81,1;79,3	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2490	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5294	107.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	318	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1658	45.8	1	SNP	p	V57M	1	.	.	169	171	ATG	861	863	ATG	110;110;110	A;T;G	99;99;99	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
